Senti Bio appoints Jay Cross as CFO

Senti Bio (SNTI)sciences announced an expansion of its senior leadership team with the addition of Jay Cross as CFO and Faraz Siddiqui as Senior Vice President of Technical Operations. Mr. Cross will join the Company on March 3, 2025. Mr. Siddiqui joined the Company in January 2025. Mr. Cross will oversee the Company’s financial strategy and operations, and investor relations to support its continued growth and clinical development of SENTI-202 and SENTI-301A. Mr. Siddiqui oversees the Company’s process development, manufacturing, and supply chain. Cross enjoyed a 20-year career on Wall Street, where he served as a managing director in the healthcare investment banking practice at Chardan. Prior to joining Senti Bio, Siddiqui was Senior Vice President, Manufacturing Operations at IGM Biosciences